Exec Chat: Glooko CEO Talks Differentiation, Collaboration And The Future Of Digital Diabetes Solutions
Medtech Insight talked to Russ Johannesson about Glooko’s connected diabetes care strategy, including its recent agreement with John Hopkins HealthCare Solutions and acquisition of Diabnext, a French competitor.
You may also be interested in...
Glooko said it will integrate Xbird’s JITAI digital coaching platform into its existing diabetes management platform.
Lilly announced it signed strategic international agreements with four diabetes companies to advance connected solutions and streamline care for people with diabetes in markets outside of the US.
Glooko will use the proceeds to expand into new geographies and take advantage of rising reimbursement for digital health, expand solutions for co-morbid conditions, and explore tuck-in acquisitions.